Tags

Type your tag names separated by a space and hit enter

Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992 to 1995.
Aust N Z J Public Health 1997; 21(7):716-21AN

Abstract

To assess changes in knowledge and use of folic acid supplements in relation to a statewide health promotion project for the prevention of neural tube defects, we surveyed general practitioners, pharmacists, women of child-bearing age and pregnant women in Western Australia. We also collected data on wholesale sales of folic acid supplements. By the end of the project, 56.5 per cent of general practitioner respondents knew that the recommended dose of folic acid was 0.5 mg and 70 per cent offered folic acid supplements to women planning pregnancy, 82.5 per cent of responding pharmacists knew the recommended dose, and 87.5 per cent reported an increase in sales of 0.5 mg folic acid. Wholesale sales of 0.5 mg folic acid increased markedly in Western Australia compared with other states. From shopping centre surveys of women of child-bearing age we estimated that their knowledge of the association between folate and spina bifida increased from 8.2 per cent before the project to 67.5 per cent 2.5 years later, and doctors were a major source of information for women. In a 1995 survey of a sample of pregnant women, 43.1 per cent with planned pregnancies had taken folic acid supplements periconceptionally, compared with 19.1 per cent in a similar survey in 1993.

Authors+Show Affiliations

TVW Telethon Institute for Child Health Research, West Perth, WA 6872, USA. carolb@ichr.uwa.edu.auNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

9489188

Citation

Bower, C, et al. "Promotion of Folate for the Prevention of Neural Tube Defects: Knowledge and Use of Periconceptional Folic Acid Supplements in Western Australia, 1992 to 1995." Australian and New Zealand Journal of Public Health, vol. 21, no. 7, 1997, pp. 716-21.
Bower C, Blum L, O'Daly K, et al. Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992 to 1995. Aust N Z J Public Health. 1997;21(7):716-21.
Bower, C., Blum, L., O'Daly, K., Higgins, C., Loutsky, F., & Kosky, C. (1997). Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992 to 1995. Australian and New Zealand Journal of Public Health, 21(7), pp. 716-21.
Bower C, et al. Promotion of Folate for the Prevention of Neural Tube Defects: Knowledge and Use of Periconceptional Folic Acid Supplements in Western Australia, 1992 to 1995. Aust N Z J Public Health. 1997;21(7):716-21. PubMed PMID: 9489188.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992 to 1995. AU - Bower,C, AU - Blum,L, AU - O'Daly,K, AU - Higgins,C, AU - Loutsky,F, AU - Kosky,C, PY - 1998/3/7/pubmed PY - 1998/3/7/medline PY - 1998/3/7/entrez SP - 716 EP - 21 JF - Australian and New Zealand journal of public health JO - Aust N Z J Public Health VL - 21 IS - 7 N2 - To assess changes in knowledge and use of folic acid supplements in relation to a statewide health promotion project for the prevention of neural tube defects, we surveyed general practitioners, pharmacists, women of child-bearing age and pregnant women in Western Australia. We also collected data on wholesale sales of folic acid supplements. By the end of the project, 56.5 per cent of general practitioner respondents knew that the recommended dose of folic acid was 0.5 mg and 70 per cent offered folic acid supplements to women planning pregnancy, 82.5 per cent of responding pharmacists knew the recommended dose, and 87.5 per cent reported an increase in sales of 0.5 mg folic acid. Wholesale sales of 0.5 mg folic acid increased markedly in Western Australia compared with other states. From shopping centre surveys of women of child-bearing age we estimated that their knowledge of the association between folate and spina bifida increased from 8.2 per cent before the project to 67.5 per cent 2.5 years later, and doctors were a major source of information for women. In a 1995 survey of a sample of pregnant women, 43.1 per cent with planned pregnancies had taken folic acid supplements periconceptionally, compared with 19.1 per cent in a similar survey in 1993. SN - 1326-0200 UR - https://www.unboundmedicine.com/medline/citation/9489188/Promotion_of_folate_for_the_prevention_of_neural_tube_defects:_knowledge_and_use_of_periconceptional_folic_acid_supplements_in_Western_Australia_1992_to_1995_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1326-0200&date=1997&volume=21&issue=7&spage=716 DB - PRIME DP - Unbound Medicine ER -